Health & Beauty Pharmacy Limited - Accounts to registrar (filleted)

REGISTERED NUMBER: 02455978 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

HEALTH & BEAUTY PHARMACY LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

A Gautama

S Gautama

SECRETARY:

A Gautama

REGISTERED OFFICE:

50 Seymour Street

London

W1H 7JG

REGISTERED NUMBER:

02455978 (England and Wales)

ACCOUNTANTS:

Orcom Civvals Limited

Accountants

50 Seymour Street

London

W1H 7JG

BANKERS:

Barclays Bank plc

Chiltern House

12 Station Approach

Gerrards Cross

Buckinghamshire

SL9 8PP

FIXED ASSETS

Tangible assets

4

1,167,419

1,192,762

Investments

5

-

Investment property

6

1,025,000

2,192,419

2,217,762

CURRENT ASSETS

Stocks

-

341,181

Debtors

7

939,719

1,017,705

Cash at bank and in hand

1,832,798

2,074,743

2,772,517

3,433,629

CREDITORS

Amounts falling due within one year

8

(223,566

)

(173,185

)

NET CURRENT ASSETS

2,548,951

3,260,444

TOTAL ASSETS LESS CURRENT
LIABILITIES

4,741,370

5,478,206

PROVISIONS FOR LIABILITIES

(234,656

)

(237,163

)

NET ASSETS

4,506,714

5,241,043

CAPITAL AND RESERVES

Called up share capital

250

Fair value reserve

9

511,194

Capital redemption reserve

9

250

Revaluation reserve

9

585,708

Retained earnings

9

3,409,312

4,143,641

SHAREHOLDERS' FUNDS

4,506,714

5,241,043

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 August 2025 and were signed on its behalf by:

S Gautama - Director

1.	STATUTORY INFORMATION

Health & Beauty Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Short leasehold

-

over the term of the lease

Fixtures and fittings

-

15% on reducing balance

Computer equipment

-

25% on reducing balance

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Investment properties

Investment properties are included at fair value. Revaluation surpluses are recognised in the income statement. Deferred taxation is provided on these gains at the rate expected to apply when properties are sold.

Going concern

The directors believe that the company is well placed to manage its business risks successfully despite the current uncertain economic outlook.

The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the annual report and accounts.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2023 - 11 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

Freehold

Short

and

Computer

property

leasehold

fittings

equipment

Totals

£

COST OR VALUATION

At 1 January 2024

1,200,000

73,955

223,487

10,700

1,508,142

Disposals

-

(223,487

)

(10,700

)

(234,187

)

At 31 December 2024

1,200,000

73,955

-

1,273,955

DEPRECIATION

At 1 January 2024

18,000

70,110

217,710

9,560

315,380

Charge for year

18,000

426

-

18,426

Eliminated on disposal

-

(217,710

)

(9,560

)

(227,270

)

At 31 December 2024

36,000

70,536

-

106,536

NET BOOK VALUE

At 31 December 2024

1,164,000

3,419

-

1,167,419

At 31 December 2023

1,182,000

3,845

5,777

1,140

1,192,762

Cost or valuation at 31 December 2024 is represented by:

Freehold

Short

property

leasehold

Totals

£

Valuation in 2022

693,894

-

693,894

Cost

506,106

73,955

580,061

1,200,000

73,955

1,273,955

5.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

Additions

2,500,000

Disposals

(2,500,000

)

At 31 December 2024

-

NET BOOK VALUE

At 31 December 2024

-

6.	INVESTMENT PROPERTY

In the opinion of the director, Mr A Gautama, the book value of the investment property was a fair reflection of the market value of the investment property at the balance sheet date.

Fair value at 31 December 2024 is represented by:

£

Valuation in 2012

406,877

Valuation in 2014

150,000

Valuation in 2021

80,788

Cost

387,335

1,025,000

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

Trade debtors

-

66,237

Other debtors

-

5,277

Amount due from related

company

928,125

Prepayments

11,594

18,066

939,719

1,017,705

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

Trade creditors

5,977

110,529

Tax

5,576

18,218

Other creditors

180,760

-

Directors' current account

13,976

Accrued expenses

17,277

30,462

223,566

173,185

9.

RESERVES

Fair

Capital

Retained

value

redemption

Revaluation

earnings

reserve

Totals

£

At 1 January 2024

4,143,641

511,194

250

585,708

5,240,793

Profit for the year

1,795,671

Dividends

(2,530,000

)

(2,530,000

)

At 31 December 2024

3,409,312

511,194

250

585,708

4,506,464

10.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2024 and 31 December 2023:

2024

2023

£

A Gautama

Balance outstanding at start of year

(13,976

)

(16,108

)

Amounts advanced

-

2,640

Amounts repaid

-

(508

)

Amounts written off

-

Amounts waived

-

Balance outstanding at end of year

(13,976

)

(13,976

)

11.	RELATED PARTY DISCLOSURES

Included in debtors, is an amount of £928,125 (2023: £928,125) owed by a company under common directorship.

Included in other creditors, is an amount of £180,760 (2023: £Nil) owed to a company under common control.